Currently in the U.S., two influenza vaccines are licensed exclusively for use in seniors: an egg-grown trivalent inactivated high dose (HD-IIV3) influenza vaccine (Fluzone® High-Dose, Sanofi Pasteur) and an egg-grown trivalent inactivated adjuvanted (aIIV3) influenza vaccine (Fluad®, ...